Welcome to CDC stacks | Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis - 35546 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis
  • Published Date:
    Nov 2015
  • Source:
    Emerg Infect Dis. 21(11):2098-2100
  • Language:
    English
Filetype[PDF-848.73 KB]


No Related Documents.
You May Also Like:
  1. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection
    Personal Author:
    Ford, Christopher B.; Lin, Philana Ling; Chase, Michael; Shah, Rupal R.; Iartchouk, Oleg; Galagan, James; Mohaideen, Nilofar; Ioerger, Thomas R.; Sacchettini, James C.; Lipsitch, Marc; Flynn, JoAnne L.; Fortune, Sarah M.;
    Published:
    Apr 24 2011
    Source:
    Nat Genet. 43(5):482-486.
    Description:
    Tuberculosis poses a global health emergency, which has been compounded by the emergence of drug-resistant Mycobacterium tuberculosis (Mtb) strains. We used whole-genome sequencing to compare the accumulation of mutations in Mtb isolated from cynomol...
    File Type:
    Filetype[PDF - 505.70 KB]
  2. Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
    Personal Author:
    Balcells, Maria Elvira; Thomas, Sara L.; Godfrey-Faussett, Peter; Grant, Alison D.;
    Published:
    May 2006
    Source:
    Emerg Infect Dis. 12(5):744-751.
    Description:
    In the context of tuberculosis (TB) resurgence, isoniazid preventive therapy (IPT) is increasingly promoted, but concerns about the risk for development of isoniazid-resistant tuberculosis may hinder its widespread implementation. We conducted a syst...
    File Type:
    Filetype[PDF - 223.08 KB]
  3. Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study
    Personal Author:
    Moonan, Patrick K; Teeter, Larry D; Salcedo, Katya; Ghosh, Smita; Ahuja, Shama D; Flood, Jennifer; Graviss, Edward A;
    Published:
    Jun 05 2013
    Source:
    Lancet Infect Dis. 13(9):777-784.
    Description:
    Background : Multidrug-resistant (MDR) tuberculosis is a potential threat to tuberculosis elimination, but the extent of MDR tuberculosis disease in the USA that is attributable to transmission within the country is unknown. We assessed transmission ...
    File Type:
    Filetype[PDF - 331.11 KB]
  4. The tuberculosis epidemic. Scientific challenges and opportunities.
    Personal Author:
    Ginsberg, A M
    Published:
    1998 Mar-Apr
    Source:
    Public Health Rep. 113(2):128-136
    File Type:
    Filetype[PDF - 3.88 MB]
  5. Tuberculosis from Mycobacterium bovis in Binational Communities, United States
    Personal Author:
    Rodwell, Timothy C.; Moore, Marisa; Moser, Kathleen S.; Brodine, Stephanie K.; Strathdee, Steffanie A.;
    Published:
    Jun 2008
    Source:
    Emerg Infect Dis. 14(6):909-916.
    Description:
    The epidemiology of tuberculosis (TB) in the United States is changing as the incidence of disease becomes more concentrated in foreign-born persons. Mycobacterium bovis appears to be contributing substantially to the TB incidence in some binational ...
    File Type:
    Filetype[PDF - 173.91 KB]